WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085209) TREATING T-CELL MEDIATED DISEASES BY MODULATING DR6 ACTIVITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085209    International Application No.:    PCT/US2001/011735
Publication Date: 15.11.2001 International Filing Date: 30.04.2001
Chapter 2 Demand Filed:    07.11.2001    
IPC:
C07K 14/705 (2006.01), C07K 16/28 (2006.01)
Applicants: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center DC 1104 Indianapolis, IN 46285 (US) (For All Designated States Except US).
HEUER, Josef, Georg [US/US]; (US) (For US Only).
LIU, Jinqi [CN/US]; (US) (For US Only).
NA, Songqing [US/US]; (US) (For US Only).
SONG, Ho, Yeong [US/US]; (US) (For US Only).
YANG, Derek, Di [CN/US]; (US) (For US Only)
Inventors: HEUER, Josef, Georg; (US).
LIU, Jinqi; (US).
NA, Songqing; (US).
SONG, Ho, Yeong; (US).
YANG, Derek, Di; (US)
Agent: SHARP, Robert, L.; Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285 (US)
Priority Data:
60/203,015 10.05.2000 US
Title (EN) TREATING T-CELL MEDIATED DISEASES BY MODULATING DR6 ACTIVITY
(FR) TRAITEMENT DE MALADIES INDUITES PAR LES LYMPHOCYTES T PAR MODULATION DE L'ACTIVITE DE DR6
Abstract: front page image
(EN)Novel methods are provided for the treatment or prevention of T cell mediated conditions in a mammal that comprise administering to said mammal a therapeutically effective amount of a pharmaceutical composition comprising at least one DR6 agonist or DR6 antagonist.
(FR)L'invention porte sur de nouveaux procédés utiles dans le traitement ou la prévention d'états pathologiques induits par les lymphocytes T chez un mammifère, ce procédé consistant à administrer au mammifère une quantité efficace d'un point de vue thérapeutique d'une composition pharmaceutique comprenant au moins un agoniste ou un antagoniste de DR6.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)